HIF 1 ALPHA AND PHOS S6 ARE INDEPENDENT PREDICTORS OF SURVIVAL IN CLEAR CELL RENAL CELL CARCINOMA (CCRCC)

被引:0
|
作者
Schultz, Luciana
Albadine, Roula
Hicks, Jessica
De Marzo, Angelo
Reuter, Victor
Carducci, Michael
Pili, Roberto
Argani, Pedram
Netto, George
机构
来源
JOURNAL OF UROLOGY | 2010年 / 183卷 / 04期
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
201
引用
收藏
页码:E80 / E80
页数:1
相关论文
共 50 条
  • [31] Membrane-bound peptidase activity in clear cell renal cell carcinoma (CCRCC)
    Etxezarraga, C.
    Varona, A.
    Larrinaga, G.
    Gil, J.
    Hoyos, I.
    Lopez, J. I.
    MODERN PATHOLOGY, 2007, 20 : 347A - 347A
  • [32] Transcriptional profiling in clear cell renal cell carcinoma (ccRCC). Focus on Czech Republic
    Wozniak, Magdalena B.
    Le Calvez-Kelm, Florence
    Lesueur, Fabienne
    Abedi-Ardekani, Behnoush
    Holcatova, Ivana
    Janout, Vladimir
    Foretova, Lenka
    Carreira, Christine
    Durand, Geoffroy
    Michelon, Jocelyne
    McKay, James
    Brennan, Paul
    Scelo, Ghislaine
    CANCER RESEARCH, 2012, 72
  • [33] A study on the expression of ITGA5 on clear cell renal cell carcinoma (CCRCC)
    Linares, E. M.
    Leon-Castillo, A.
    Marcos Gonzalez, S.
    de Leon Rivas, C.
    Bueno Ortiz, P. M.
    Racean, S. F.
    Herrero Blanco, E.
    Garcia Arranz, P.
    Freire Salinas, J.
    Azueta Etxebarria, A.
    Gomez-Roman, J.
    VIRCHOWS ARCHIV, 2017, 471 : S283 - S284
  • [34] Examination of a Recently Proposed Grading System for Clear Cell Renal Cell Carcinoma (CCRCC)
    Khor, L. Y.
    Reynolds, J. P.
    Przybycin, C. G.
    LABORATORY INVESTIGATION, 2014, 94 : 240A - 240A
  • [35] Examination of a Recently Proposed Grading System for Clear Cell Renal Cell Carcinoma (CCRCC)
    Khor, L. Y.
    Reynolds, J. P.
    Przybycin, C. G.
    MODERN PATHOLOGY, 2014, 27 : 240A - 240A
  • [36] TCEB1-Mutated Renal Cell Carcinoma (RCC): An Entity With Clear Cytoplasm and Prominent Fibromuscular Stroma Is Distinct From Clear Cell Renal Cell Carcinoma (ccRCC)
    Sarungbam, Judy
    Hakimi, A. Ari
    Sato, Yusuke
    Ogawa, Seishi
    Jacobsen, Anders
    Homma, Yukio
    Morikawa, Teppei
    Kume, Haruki
    Fukayama, Masahi
    Chen, Yingbei
    Gopalan, Anuradha
    Al-Ahmadie, Hikmat
    Fine, Samson
    Sirintrapun, Sahussapont
    Russo, Paul
    Hsieh, James
    Reuter, Victor
    Tickoo, Satish
    MODERN PATHOLOGY, 2015, 28 : 257A - 257A
  • [37] TCEB1-Mutated Renal Cell Carcinoma (RCC): An Entity With Clear Cytoplasm and Prominent Fibromuscular Stroma Is Distinct From Clear Cell Renal Cell Carcinoma (ccRCC)
    Sarungbam, Judy
    Hakimi, A. Ari
    Sato, Yusitke
    Ogawa, Seishi
    Jacobsen, Anders
    Homma, Yukio
    Morikawa, Teppei
    Kume, Haruki
    Fukayama, Masahi
    Chen, Yingbei
    Gopalan, Anuradha
    Al-Ahmadie, Hikmat
    Fine, Samson
    Sirintrapun, Sahussapont
    Russo, Paul
    Hsieh, James
    Reuter, Victor
    Tickoo, Satish
    LABORATORY INVESTIGATION, 2015, 95 : 257A - 257A
  • [38] Evolution of the HIF targeted therapy in clear cell renal cell carcinoma
    Golijanin, Borivoj
    Malshy, Kamil
    Khaleel, Sari
    Lagos, Galina
    Amin, Ali
    Cheng, Liang
    Golijanin, Dragan
    Mega, Anthony
    CANCER TREATMENT REVIEWS, 2023, 121
  • [39] Targeting HIF2 in Clear Cell Renal Cell Carcinoma
    Cho, Hyejin
    Kaelin, William G.
    TARGETING CANCER, VOL 81, 2016, 2016, 81 : 113 - 121
  • [40] Quantitative tumour necrosis is an independent predictor of overall survival in clear cell renal cell carcinoma
    Renshaw, Andrew A.
    Cheville, John C.
    PATHOLOGY, 2015, 47 (01) : 34 - 37